Rafarma Pharmaceuticals, Inc. (RAFA)
Makes and sells antibiotics, cancer drugs, and specialty medicines in Russia.
$0.02-0.25%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-72.9%
The outlook
RAFA is trading near the bottom of its 52-week range, sitting well below both its 50- and 200-day moving averages. The stock shows minimal analyst coverage and a bearish outlook score. Today's price reflects a slight decline in what remains a deeply depressed trend.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range18% of the way from its 52-week low to high
Market cap
$1.9M
52-wk high
$0.10
52-wk low
$0.00
50-day avg
$0.04
200-day avg
$0.05
Trailing P/E
—